GemVax & KAEL Co Ltd
KOSDAQ:082270
Net Margin
GemVax & KAEL Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
G
|
GemVax & KAEL Co Ltd
KOSDAQ:082270
|
1.3T KRW |
-139%
|
|
| NL |
|
ASML Holding NV
AEX:ASML
|
229.9B EUR |
27%
|
|
| US |
B
|
Brooks Automation Inc
LSE:0HQ1
|
243.5B USD |
-25%
|
|
| US |
|
Applied Materials Inc
NASDAQ:AMAT
|
124.3B USD |
23%
|
|
| US |
|
KLA Corp
NASDAQ:KLAC
|
92.2B USD |
30%
|
|
| US |
|
Lam Research Corp
NASDAQ:LRCX
|
91.8B USD |
27%
|
|
| JP |
|
Tokyo Electron Ltd
TSE:8035
|
9.7T JPY |
23%
|
|
| CN |
|
NAURA Technology Group Co Ltd
SZSE:002371
|
241.3B CNY |
20%
|
|
| JP |
|
Advantest Corp
TSE:6857
|
4.2T JPY |
21%
|
|
| NL |
|
ASM International NV
AEX:ASM
|
21B EUR |
23%
|
|
| JP |
|
Disco Corp
TSE:6146
|
3T JPY |
32%
|
GemVax & KAEL Co Ltd
Glance View
GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-06-24. The firm and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The firm distributes its products within domestic market and to overseas markets.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on GemVax & KAEL Co Ltd's most recent financial statements, the company has Net Margin of -139.1%.
You don't have any saved screeners yet